HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$23.40
Day range
$22.45 - $23.56
Year range
$14.89 - $32.53
Market cap
2.05B USD
Avg Volume
639.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 67.38M | 8.33% |
Net income | -62.05M | -6.38% |
Net profit margin | — | — |
Earnings per share | -0.66 | 9.59% |
EBITDA | -65.12M | -7.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 330.31M | -0.23% |
Total assets | 499.44M | -2.98% |
Total liabilities | 57.94M | 3.68% |
Total equity | 441.50M | — |
Shares outstanding | 90.78M | — |
Price to book | 4.80 | — |
Return on assets | -31.61% | — |
Return on capital | -34.20% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -62.05M | -6.38% |
Cash from operations | -56.86M | 1.22% |
Cash from investing | 35.03M | 195.41% |
Cash from financing | 1.18M | -93.55% |
Net change in cash | -20.64M | 72.82% |
Free cash flow | -57.44M | -47.56% |
About
Founded
1999
Website
Employees
268